Soft tissue sarcoma
Soft tissue sarcoma is a diverse group of mesenchymal malignancies of fat, muscle, nerve, vessel, and fibrous tissue, confirmed only by biopsy and staged mainly by histologic grade and hematogenous (usually pulmonary) spread. A mass 5 cm or larger, deep to fascia, fixed, rapidly enlarging, recurrent, or painful without explanation should be imaged and biopsied before any excision.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
A family of mesenchymal malignancies, not one disease: soft tissue sarcoma (STS) arises from fat (liposarcoma), smooth muscle (leiomyosarcoma), striated muscle (rhabdomyosarcoma), fibrous/dermal…
- Epidemiology
Age and histology split by life stage: rhabdomyosarcoma is the most common soft tissue sarcoma in children; liposarcoma and leiomyosarcoma predominate in adults.
- Risk factors
Li-Fraumeni syndrome (germline TP53, autosomal dominant): soft tissue and bone sarcomas, leukemia, breast cancer, brain tumors, and adrenocortical carcinoma; a confirmed carrier begins annual breast…
- Pathophysiology
Tissue-specific histogenesis: each subtype mirrors its cell of origin, for example smooth muscle to leiomyosarcoma, striated muscle to rhabdomyosarcoma, fat to liposarcoma, endothelium to…
- Clinical features
A firm, enlarging soft tissue mass is typical, and any mass with a red-flag feature should be evaluated as possible sarcoma rather than observed: 5 cm or larger, deep to fascia, rapidly enlarging…
- Differential diagnosis
Lipoma: the most common mimic; soft, freely mobile, painless, superficial, lacking the red-flag features above.
- Diagnosis
Diagnosis is established by histopathology, not clinical criteria: biopsy assigns histologic subtype (morphology and immunohistochemistry) and grade (differentiation and mitotic activity, low-grade…
- Management
First, refer any biopsy-confirmed or strongly suspected sarcoma to a multidisciplinary team (surgical oncology, radiation oncology, medical oncology) before treatment, since outcomes depend on coordinated planning around the biopsy tract.
- Complications
Local recurrence, particularly after an unplanned excisional biopsy or incomplete resection that contaminated surrounding tissue planes.
- Prognosis
Histologic grade and stage (local extent, nodal spread, and especially distant metastasis) together determine outcome, with stage generally carrying more prognostic weight than grade, since…
- Prevention
There is no general-population screening test for sporadic soft tissue sarcoma; prevention rests on recognizing red-flag features early (5 cm or larger, deep to fascia, fixed, rapidly enlarging…
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.
Related articles
- Bone tumors
Bone tumors range from benign lesions such as osteochondroma and osteoid osteoma to aggressive primary malignancies such as osteosarcoma, chondrosarcoma, and Ewing sarcoma. The diagnostic approach is a radiograph first to characterize the lesion as benign or aggressive, then MRI for local extent, then image-guided biopsy as the confirmatory step, with management ranging from observation to resection and chemotherapy.
- Kaposi sarcoma
Kaposi sarcoma is a human herpesvirus 8-associated vascular malignancy that presents as violaceous macules, papules, plaques, or tumors of the skin, mouth, gastrointestinal tract, or lungs, most often in HIV-associated, transplant-related, or classic elderly disease. Diagnosis is confirmed by biopsy. Every patient with HIV-associated Kaposi sarcoma starts or optimizes antiretroviral therapy, with liposomal doxorubicin 20 mg/m2 intravenously every 21 days added for extensive or visceral disease.
- Uterine fibroids
Uterine leiomyomas are benign monoclonal smooth-muscle tumors of the myometrium that cause heavy menstrual bleeding, bulk symptoms, and reproductive dysfunction; management ranges from expectant care to hormonal bleeding control to fertility-sparing or definitive surgery.
- Neurofibromatosis type 1
Autosomal dominant neurocutaneous disorder from NF1 tumor suppressor mutations causing cafe-au-lait macules, neurofibromas, Lisch nodules, and optic glioma; diagnosed clinically by consensus criteria and managed with surveillance, surgery for symptomatic tumors, and selumetinib for inoperable plexiform neurofibromas.
- Lipoma
A lipoma is a benign, freely mobile subcutaneous fat tumor that is diagnosed clinically on the basis of a soft, painless, slowly growing mass and managed with observation unless the lesion is symptomatic, atypical, or the patient requests removal, in which case elective excision is curative. Features that break the typical pattern, size 5 cm or larger, deep or fascial fixation, rapid growth, or unexplained pain, should trigger imaging and specialist evaluation to exclude liposarcoma rather than routine removal.
- Lymphedema
Lymphedema is chronic tissue swelling from impaired lymphatic drainage, primary (developmental) or secondary (from surgery, radiation, infection, or malignancy). It causes progressive non-pitting edema that involves the toes, and management is decongestive therapy with compression, skin care, and cellulitis prevention, since there is no curative drug.
- Colon polyposis and hereditary colorectal cancer syndromes
Five inherited syndromes drive colorectal cancer risk through distinct genes and polyp biology: FAP and MUTYH-associated polyposis through adenomas, Lynch syndrome through mismatch-repair loss, and Peutz-Jeghers and juvenile polyposis through hamartomas. Each carries its own inheritance pattern, surveillance schedule, and threshold for surgery.
- Necrotizing fasciitis
Necrotizing fasciitis is a rapidly progressive, life-threatening infection of the subcutaneous tissue and superficial fascia driven by vessel thrombosis and bacterial exotoxin production. The hallmark is pain out of proportion to visible skin findings, with crepitus, bullae, and woody induration in advanced disease. Diagnosis is confirmed by direct surgical exploration; the LRINEC score aids risk stratification. Treatment is emergent surgical debridement combined with broad-spectrum empiric antibiotics.
- Cellulitis
Cellulitis is a nonpurulent, spreading infection of the deep dermis and subcutaneous fat, usually caused by beta-hemolytic streptococci, diagnosed clinically and treated with antibiotics alone since there is no collection to drain.